FDANews
FDAnews Device Daily Bulletin

AtriCure Begins Enrollment of Atrial Fibrillation Study

Dec. 18, 2015

AtriCure has enrolled the first patient in its CEASE AF clinical study, which will compare the results of a combined epicardial surgical plus endocardial catheter technique versus a standard endocardial catheter ablation technique for patients with persistent or long-standing atrial fibrillation.

The study — which will cover more than 200 patients — is intended to demonstrate additional evidence for a combined surgical plus catheter ablation approach as a therapy for the stand-alone treatment atrial fibrillation.

Recent studies have indicated that hybrid ablation has higher success rates without the need for further interventions, according to AtriCure. — Michael Cipriano